Cargando…
Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey
BACKGROUND: Decisions about the continued need for control measures to contain the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rely on accurate and up-to-date information about the number of people testing positive for SARS-CoV-2 and risk factors for testing positive. Exis...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786000/ https://www.ncbi.nlm.nih.gov/pubmed/33308423 http://dx.doi.org/10.1016/S2468-2667(20)30282-6 |
_version_ | 1783632541459152896 |
---|---|
author | Pouwels, Koen B House, Thomas Pritchard, Emma Robotham, Julie V Birrell, Paul J Gelman, Andrew Vihta, Karina-Doris Bowers, Nikola Boreham, Ian Thomas, Heledd Lewis, James Bell, Iain Bell, John I Newton, John N Farrar, Jeremy Diamond, Ian Benton, Pete Walker, Ann Sarah |
author_facet | Pouwels, Koen B House, Thomas Pritchard, Emma Robotham, Julie V Birrell, Paul J Gelman, Andrew Vihta, Karina-Doris Bowers, Nikola Boreham, Ian Thomas, Heledd Lewis, James Bell, Iain Bell, John I Newton, John N Farrar, Jeremy Diamond, Ian Benton, Pete Walker, Ann Sarah |
author_sort | Pouwels, Koen B |
collection | PubMed |
description | BACKGROUND: Decisions about the continued need for control measures to contain the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rely on accurate and up-to-date information about the number of people testing positive for SARS-CoV-2 and risk factors for testing positive. Existing surveillance systems are generally not based on population samples and are not longitudinal in design. METHODS: Samples were collected from individuals aged 2 years and older living in private households in England that were randomly selected from address lists and previous Office for National Statistics surveys in repeated cross-sectional household surveys with additional serial sampling and longitudinal follow-up. Participants completed a questionnaire and did nose and throat self-swabs. The percentage of individuals testing positive for SARS-CoV-2 RNA was estimated over time by use of dynamic multilevel regression and poststratification, to account for potential residual non-representativeness. Potential changes in risk factors for testing positive over time were also assessed. The study is registered with the ISRCTN Registry, ISRCTN21086382. FINDINGS: Between April 26 and Nov 1, 2020, results were available from 1 191 170 samples from 280 327 individuals; 5231 samples were positive overall, from 3923 individuals. The percentage of people testing positive for SARS-CoV-2 changed substantially over time, with an initial decrease between April 26 and June 28, 2020, from 0·40% (95% credible interval 0·29–0·54) to 0·06% (0·04–0·07), followed by low levels during July and August, 2020, before substantial increases at the end of August, 2020, with percentages testing positive above 1% from the end of October, 2020. Having a patient-facing role and working outside your home were important risk factors for testing positive for SARS-CoV-2 at the end of the first wave (April 26 to June 28, 2020), but not in the second wave (from the end of August to Nov 1, 2020). Age (young adults, particularly those aged 17–24 years) was an important initial driver of increased positivity rates in the second wave. For example, the estimated percentage of individuals testing positive was more than six times higher in those aged 17–24 years than in those aged 70 years or older at the end of September, 2020. A substantial proportion of infections were in individuals not reporting symptoms around their positive test (45–68%, dependent on calendar time. INTERPRETATION: Important risk factors for testing positive for SARS-CoV-2 varied substantially between the part of the first wave that was captured by the study (April to June, 2020) and the first part of the second wave of increased positivity rates (end of August to Nov 1, 2020), and a substantial proportion of infections were in individuals not reporting symptoms, indicating that continued monitoring for SARS-CoV-2 in the community will be important for managing the COVID-19 pandemic moving forwards. FUNDING: Department of Health and Social Care. |
format | Online Article Text |
id | pubmed-7786000 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Author(s). Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77860002021-01-11 Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey Pouwels, Koen B House, Thomas Pritchard, Emma Robotham, Julie V Birrell, Paul J Gelman, Andrew Vihta, Karina-Doris Bowers, Nikola Boreham, Ian Thomas, Heledd Lewis, James Bell, Iain Bell, John I Newton, John N Farrar, Jeremy Diamond, Ian Benton, Pete Walker, Ann Sarah Lancet Public Health Articles BACKGROUND: Decisions about the continued need for control measures to contain the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rely on accurate and up-to-date information about the number of people testing positive for SARS-CoV-2 and risk factors for testing positive. Existing surveillance systems are generally not based on population samples and are not longitudinal in design. METHODS: Samples were collected from individuals aged 2 years and older living in private households in England that were randomly selected from address lists and previous Office for National Statistics surveys in repeated cross-sectional household surveys with additional serial sampling and longitudinal follow-up. Participants completed a questionnaire and did nose and throat self-swabs. The percentage of individuals testing positive for SARS-CoV-2 RNA was estimated over time by use of dynamic multilevel regression and poststratification, to account for potential residual non-representativeness. Potential changes in risk factors for testing positive over time were also assessed. The study is registered with the ISRCTN Registry, ISRCTN21086382. FINDINGS: Between April 26 and Nov 1, 2020, results were available from 1 191 170 samples from 280 327 individuals; 5231 samples were positive overall, from 3923 individuals. The percentage of people testing positive for SARS-CoV-2 changed substantially over time, with an initial decrease between April 26 and June 28, 2020, from 0·40% (95% credible interval 0·29–0·54) to 0·06% (0·04–0·07), followed by low levels during July and August, 2020, before substantial increases at the end of August, 2020, with percentages testing positive above 1% from the end of October, 2020. Having a patient-facing role and working outside your home were important risk factors for testing positive for SARS-CoV-2 at the end of the first wave (April 26 to June 28, 2020), but not in the second wave (from the end of August to Nov 1, 2020). Age (young adults, particularly those aged 17–24 years) was an important initial driver of increased positivity rates in the second wave. For example, the estimated percentage of individuals testing positive was more than six times higher in those aged 17–24 years than in those aged 70 years or older at the end of September, 2020. A substantial proportion of infections were in individuals not reporting symptoms around their positive test (45–68%, dependent on calendar time. INTERPRETATION: Important risk factors for testing positive for SARS-CoV-2 varied substantially between the part of the first wave that was captured by the study (April to June, 2020) and the first part of the second wave of increased positivity rates (end of August to Nov 1, 2020), and a substantial proportion of infections were in individuals not reporting symptoms, indicating that continued monitoring for SARS-CoV-2 in the community will be important for managing the COVID-19 pandemic moving forwards. FUNDING: Department of Health and Social Care. The Author(s). Published by Elsevier Ltd. 2021-01 2020-12-11 /pmc/articles/PMC7786000/ /pubmed/33308423 http://dx.doi.org/10.1016/S2468-2667(20)30282-6 Text en © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Articles Pouwels, Koen B House, Thomas Pritchard, Emma Robotham, Julie V Birrell, Paul J Gelman, Andrew Vihta, Karina-Doris Bowers, Nikola Boreham, Ian Thomas, Heledd Lewis, James Bell, Iain Bell, John I Newton, John N Farrar, Jeremy Diamond, Ian Benton, Pete Walker, Ann Sarah Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey |
title | Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey |
title_full | Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey |
title_fullStr | Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey |
title_full_unstemmed | Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey |
title_short | Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey |
title_sort | community prevalence of sars-cov-2 in england from april to november, 2020: results from the ons coronavirus infection survey |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786000/ https://www.ncbi.nlm.nih.gov/pubmed/33308423 http://dx.doi.org/10.1016/S2468-2667(20)30282-6 |
work_keys_str_mv | AT pouwelskoenb communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey AT housethomas communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey AT pritchardemma communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey AT robothamjuliev communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey AT birrellpaulj communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey AT gelmanandrew communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey AT vihtakarinadoris communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey AT bowersnikola communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey AT borehamian communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey AT thomasheledd communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey AT lewisjames communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey AT belliain communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey AT belljohni communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey AT newtonjohnn communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey AT farrarjeremy communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey AT diamondian communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey AT bentonpete communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey AT walkerannsarah communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey AT communityprevalenceofsarscov2inenglandfromapriltonovember2020resultsfromtheonscoronavirusinfectionsurvey |